Principal Investigator: Paul Bernstein
Keywords: prenatal vitamins , vision health Department: Ophthalmology-Services
IRB Number: 00116610 Co Investigator: Michael Varner
Specialty: Ophthalmology, Ophthalmology
Sub Specialties: Retinal Diseases, Comprehensive Ophthalmology
Recruitment Status: Recruiting

Contact Information

Susan Allman

Simple Summary

The purpose of this study is to characterize the effects of prenatal supplementation with the carotenoids lutein and zeaxanthin both in the mothers and their newborn infants. No OTC prenatal vitamins currently available contain these nutrients, however they are commonly recommended for older adults at risk for developing age-related macular degeneration.

Inclusion Criteria

Pregnant women, 18 or older of all races and ethnicities who:

  • have an uncomplicated obstetric history

  • plan to deliver either vaginally or by Caesarian section at the University of Utah for their current pregnancy


Exclusion Criteria

Women will be excluded if they:

  • Have regularly taken carotenoid supplements containing more than 0.5 mg of lutein and/or zeaxanthin daily during the past six months.

  • Have significant eye disease associated with macular pigment abnormalities such as Stargardt disease, albinism, or macular telangiectasia type II (MacTel).

  • Have any conditions associated with high-risk pregnancies such as adolescent pregnancy, multiparity, current or past history of diabetes, pre-eclampsia, previous premature delivery, drug abuse, or other significant medical illness. 

Participant Reimbursement

Participants receive OTC prenatal multivitamins for the duration of her pregnancy and through 3 months following delivery, the study supplements, and a total maximum of $125 in gift cards for completing all study visits.